FTC sues big pharmacy gain supervisors over insulin price ranges The company brought motion towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of lifestyle-saving insulin medication. Elevance lowers guidance on ‘unprecedented’ Medicaid troubles Executives explained the increased charg... https://daltonawmiz.is-blog.com/37029532/healthcare-news-an-overview